BONESUPPORT™ ANNOUNCES DISTRIBUTOR PARTNERSHIP WITH STRYKER IN AUSTRALIA AND NEW ZEALAND
BONESUPPORT, a leading orthobiologics company focused on the management of bone injuries, today announces a new distributor partnership with Stryker Australia Pty Ltd. The partnership includes BONESUPPORT’s entry into the New Zealand market and a transition to Stryker as a distributor in Australia, planned for Q4 2026. These changes support BONESUPPORT’s regional expansion and planned distributor transition across New Zealand and Australia.
For more information contact:
BONESUPPORT AB
Torbjörn Sköld, CEO
+46 (0) 46 286 53 70
Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com
Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se
About BONESUPPORT™
BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to 1,175 msek in 2025. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.